File: /home/govancoz/mail/new/1760496565.M358726P1950962.zacp120.webway.host,S=7709,W=7790
Return-Path: <foxandgunn@4fast.net>
Delivered-To: govancoz@zacp120.webway.host
Received: from zacp120.webway.host
by zacp120.webway.host with LMTP
id CNQfE7UL72jyxB0A8rC0kQ
(envelope-from <foxandgunn@4fast.net>)
for <govancoz@zacp120.webway.host>; Wed, 15 Oct 2025 04:49:25 +0200
Return-path: <foxandgunn@4fast.net>
Envelope-to: recep@govan.co.za
Delivery-date: Wed, 15 Oct 2025 04:49:25 +0200
Received: from ns1.rootautomation.com ([162.254.180.27]:62192 helo=mail.4fast.net)
by zacp120.webway.host with esmtps (TLS1.3) tls TLS_AES_256_GCM_SHA384
(Exim 4.98.2)
(envelope-from <foxandgunn@4fast.net>)
id 1v8rZs-00000008NO6-3PWJ
for recep@govan.co.za;
Wed, 15 Oct 2025 04:49:25 +0200
Received: (qmail 52768 invoked by uid 89); 12 Oct 2025 22:59:02 -0000
Received: from c155-179.i01-7.onvol.net (HELO ws-dip-gc02.diplomat.com.mt) (foxandgunn@4fast.net@212.56.155.179)
by ns1.rootautomation.com with ESMTPA; 12 Oct 2025 22:59:02 -0000
Content-Type: multipart/alternative; boundary="===============0361145571=="
MIME-Version: 1.0
Subject: Proposal for Strategic Business Collaboration.
To: Recipients <foxandgunn@4fast.net>
From: "Dr. Shingo Iwamoto" <foxandgunn@4fast.net>
Date: Mon, 13 Oct 2025 00:58:32 +0200
Reply-To: drshingoiwamotopharm1@gmail.com
X-Spam-Status: No, score=2.5
X-Spam-Score: 25
X-Spam-Bar: ++
X-Ham-Report: =?ISO-8859-1?Q?Spam_detection_software=2C_running_on_the_system_=22zacp120=2Ewebway?= =?ISO-8859-1?Q?=2Ehost=22=2C=0A_has_NOT_identified_this_incoming_ema?= =?ISO-8859-1?Q?il_as_spam=2E__The_original=0A_message_has_been_attac?= =?ISO-8859-1?Q?hed_to_this_so_you_can_view_it_or_label=0A_similar_fu?= =?ISO-8859-1?Q?ture_email=2E__If_you_have_any_questions=2C_see=0A_ro?= =?ISO-8859-1?Q?ot=5C=40localhost_for_details=2E=0A_Content_preview=3A_?= =?ISO-8859-1?Q?_Dear_Esteemed_Professional=2C_I_hope_this_message_fi?= =?ISO-8859-1?Q?nds_you=0A___well=2E_Nichi-Iko_Pharmaceutical_Co=2E=2C?= =?ISO-8859-1?Q?_Ltd=2E=2C_a_leading_pharmaceutical_manufacturer=0A__?= =?ISO-8859-1?Q?__based_in_Japan=2C_is_currently_seeking_a_qualified_?= =?ISO-8859-1?Q?individual_to_=5B=2E=2E=2E=5D_=0A_Content_analysis_de?= =?ISO-8859-1?Q?tails=3A___=282=2E5_points=2C_5=2E0_required=29=0A__p?= =?ISO-8859-1?Q?ts_rule_name______________description=0A_----_-------?= =?ISO-8859-1?Q?---------------_-------------------------------------?= =?ISO-8859-1?Q?-------------=0A__0=2E0_RCVD=5FIN=5FVALIDITY=5FRPBL=5FB?= =?ISO-8859-1?Q?LOCKED_RBL=3A_ADMINISTRATOR_NOTICE=3A_The_query_to=0A_?= =?ISO-8859-1?Q?_____________________________Validity_was_blocked=2E_?= =?ISO-8859-1?Q?_See=0A_____________________________https=3A//knowled?= =?ISO-8859-1?Q?ge=2Evalidity=2Ecom/hc/en-us/articles/20961730681243=0A_?= =?ISO-8859-1?Q?_____________________________for_more_information=2E=0A?= =?ISO-8859-1?Q?____________________________=5B162=2E254=2E180=2E27_l?= =?ISO-8859-1?Q?isted_in_bl=2Escore=2Esenderscore=2Ecom=5D=0A__0=2E0_?= =?ISO-8859-1?Q?RCVD=5FIN=5FVALIDITY=5FCERTIFIED=5FBLOCKED_RBL=3A_ADM?= =?ISO-8859-1?Q?INISTRATOR_NOTICE=3A_The=0A__________________________?= =?ISO-8859-1?Q?___query_to_Validity_was_blocked=2E__See=0A__________?= =?ISO-8859-1?Q?___________________https=3A//knowledge=2Evalidity=2Ec?= =?ISO-8859-1?Q?om/hc/en-us/articles/20961730681243=0A_______________?= =?ISO-8859-1?Q?_______________for_more_information=2E=0A____________?= =?ISO-8859-1?Q?_____________=5B162=2E254=2E180=2E27_listed_in_sa-tru?= =?ISO-8859-1?Q?sted=2Ebondedsender=2Eorg=5D=0A__0=2E0_RCVD=5FIN=5FVA?= =?ISO-8859-1?Q?LIDITY=5FSAFE=5FBLOCKED_RBL=3A_ADMINISTRATOR_NOTICE=3A_?= =?ISO-8859-1?Q?The_query_to=0A______________________________Validity?= =?ISO-8859-1?Q?_was_blocked=2E__See=0A_____________________________h?= =?ISO-8859-1?Q?ttps=3A//knowledge=2Evalidity=2Ecom/hc/en-us/articles?= =?ISO-8859-1?Q?/20961730681243=0A______________________________for_m?= =?ISO-8859-1?Q?ore_information=2E=0A_____________________________=5B1?= =?ISO-8859-1?Q?62=2E254=2E180=2E27_listed_in_sa-accredit=2Ehabeas=2Ec?= =?ISO-8859-1?Q?om=5D=0A__0=2E5_JMQ=5FSPF=5FNEUTRAL________ASKDNS=3A_?= =?ISO-8859-1?Q?SPF_set_to_=3Fall=0A_____________________________=5B4?= =?ISO-8859-1?Q?fast=2Enet_TXT=3Av=3Dspf1_ip4=3A169=2E254=2E180=2E0/2?= =?ISO-8859-1?Q?2=5D=0A_____________________________=5Bip4=3A184=2E10?= =?ISO-8859-1?Q?5=2E155=2E0/24_ip4=3A184=2E105=2E161=2E0/24=5D=0A____?= =?ISO-8859-1?Q?_________________________=5Bip4=3A216=2E7=2E118=2E9_i?= =?ISO-8859-1?Q?p4=3A66=2E220=2E13=2E18=5D=0A________________________?= =?ISO-8859-1?Q?_____=5Bip4=3A216=2E7=2E112=2E166_ip4=3A12=2E248=2E18?= =?ISO-8859-1?Q?4=2E50_mx=5D=0A_____________________________=5B=3Fall?= =?ISO-8859-1?Q?=5D=0A_-0=2E0_SPF=5FPASS_______________SPF=3A_sender_?= =?ISO-8859-1?Q?matches_SPF_record=0A__0=2E0_KAM=5FDMARC=5FSTATUS____?= =?ISO-8859-1?Q?___Test_Rule_for_DKIM_or_SPF_Failure_with_Strict=0A__?= =?ISO-8859-1?Q?___________________________Alignment=0A__0=2E2_FREEMA?= =?ISO-8859-1?Q?IL=5FREPLYTO=5FEND=5FDIGIT_Reply-To_freemail_username?= =?ISO-8859-1?Q?_ends_in_digit=0A_____________________________=5Bdrsh?= =?ISO-8859-1?Q?ingoiwamotopharm1=28at=29gmail=2Ecom=5D=0A__0=2E0_HTM?= =?ISO-8859-1?Q?L=5FMESSAGE___________BODY=3A_HTML_included_in_messag?= =?ISO-8859-1?Q?e=0A__1=2E8_FREEMAIL=5FFORGED=5FREPLYTO_Freemail_in_R?= =?ISO-8859-1?Q?eply-To=2C_but_not_From?=
X-Spam-Flag: NO
You will not see this in a MIME-aware mail reader.
--===============0361145571==
Content-Type: text/plain; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
Dear Esteemed Professional,
I hope this message finds you well.
Nichi-Iko Pharmaceutical Co., Ltd., a leading pharmaceutical manufacturer =
based in Japan, is currently seeking a qualified individual to serve as our=
official representative in South Africa. This role involves managing miner=
al procurement and overseeing the establishment of our annex office in Sout=
h Africa under a five-year contractual agreement.
This is a strategic opportunity to represent a respected global brand and =
play a key role in expanding our international presence. We are offering a =
competitive compensation package along with decision-making autonomy.
If you are interested in learning more, kindly respond to this message for=
further details.
Warm regards,
Dr. Shingo Iwamoto
President & CEO
Nichi-Iko Pharmaceutical Co., Ltd.
5-4 Nihonbashi-Honcho 1-chome, Chuo-ku, Tokyo, Japan
--===============0361145571==
Content-Type: text/html; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
<HTML><head><meta http-equiv=3D"Content-Type" content=3D"text/html; charset=
=3Diso-8859-1"/></head><BODY><P>Dear Esteemed Professional,</P>
<P>I hope this message finds you well.</P>
<P>Nichi-Iko Pharmaceutical Co., Ltd., a leading pharmaceutical manufacture=
r based in Japan, is currently seeking a qualified individual to serve as o=
ur official representative in South Africa. This role involves managing min=
eral procurement and overseeing the establishment of our annex office in So=
uth Africa under a five-year contractual agreement.</P>
<P>This is a strategic opportunity to represent a respected global brand an=
d play a key role in expanding our international presence. We are offering =
a competitive compensation package along with decision-making autonomy.</P>
<P>If you are interested in learning more, kindly respond to this message f=
or further details.</P>
<P>Warm regards,<BR>Dr. Shingo Iwamoto<BR>President & CEO<BR>Nichi-Iko =
Pharmaceutical Co., Ltd.<BR>5-4 Nihonbashi-Honcho 1-chome, Chuo-ku, Tokyo, =
Japan</P></BODY></HTML>
--===============0361145571==--